Gapping up
In reaction to strong earnings/guidance:
- APOP +25.4%, CAPR +18.6%, AKAM +8.5%, MDCO +8.1%, IRBT +5.6%, USNA +4.5%, WBA +4.4%, MKSI +4.3%, KRA +4.1%, LPL +4.1%, RES +3.5%, RGC +3.4%, BTI +3.1%, (provides update to outlook at its Capital Markets Day), TUP +3%, NOC +2.9%, TSS +2.7%, OFG +2.5%, FLIR +2.5%, AMED +2.4%, WB +2.3%, (also commences $700 mln offering of convertible senior notes due 2022 ), ILMN +2%, COF +1.9%, LYG +1.7%, HES +1.7%, SIX +1.5%, VNOM +1.4%, BXMT +1.4%, SIRI +1.4%, AVY +1.1%, CNI +1%, NUVA +1%, CEO +0.8%, AOS +0.8%, BAX +0.6%
M&A news:
- S +1.4% (T-Mobile US and Sprint (S) are preparing Boards for merger decision, according to Reuters)
Other news:
- BONT +21.2% (after closing near highs on credit facility update)
- OSTK +4.4% (extending today's move higher after confirming key details on tZERO's ICO at Money 20/20 )
- LL +4.4% (disclosed memorandum of understanding to settle class actions related to Chinese-Laminate flooring )
- SENS +3.3% (continued strength)
- ANTM +2.8% (announces that the Co has successfully activated fifteen clinical trial sites in the pivotal Phase 3 SIERRA trial for Iomab-B)
- MZOR +2.3% (reports 379-Patient controlled study also reveals seven-fold reduction in revision surgery)
- AMC +1.4% (following RGC results)
- TNDM +1.1% (to make any new features approved for the t:slim X2 Insulin Pump by the FDA in 2018 available to all in-warranty users at no cost through the Tandem Device Updater )
- VRAY +0.9% (raised approx $50 mln through offering)
Analyst comments:
- ALDX +4.8% (initiated with a Overweight at Cantor Fitzgerald)
- ILMN +2% (upgraded to Outperform at Robert W. Baird)
- LDOS +1.4% (upgraded to Outperform from Market Perform at Wells Fargo)
- UAL +1% (upgraded to Outperform at Evercore ISI)